IHC-P analysis of human stomach carcinoma tissue using GTX03465 CLN6 antibody. Left : Primary antibody Right : Negative control; PBS instead of primary antibody. Dilution : 1:50
IHC-P analysis of human stomach carcinoma tissue using GTX03465 CLN6 antibody. Left : Primary antibody Right : Negative control; PBS instead of primary antibody. Dilution : 1:50
CLN6 antibody
GTX03465
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Rat
TargetCLN6
Overview
- SupplierGeneTex
- Product NameCLN6 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:1000. IHC-P: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID54982
- Target nameCLN6
- Target descriptionCLN6 transmembrane ER protein
- Target synonymsceroid-lipofuscinosis neuronal 6 late infantile; ceroid-lipofuscinosis neuronal protein 6; ceroid-lipofuscinosis, neuronal 6, late infantile; CLN4A; HsT18960; nclf
- HostRabbit
- IsotypeIgG
- Protein IDQ9NWW5
- Protein NameCeroid-lipofuscinosis neuronal protein 6
- Scientific DescriptionThis gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]
- ReactivityHuman, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203